Gene · 652995
Papers3,485
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
221 to 240 of 3,485
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Preeclampsia-associated lncRNA FEZF1-AS1 regulates cell proliferation and apoptosis in placental trophoblast cells through the ELAVL1/NOC2L axis. | Cell Div | 2023 | 37872600 | PubTator, text mining | PubMed |
| Candidate genes for domestication and resistance to cold climate according to whole genome sequencing data of Russian cattle and sheep breeds. | Vavilovskii Zhurnal Genet Selektsii | 2023 | 37867610 | PubTator, text mining | PubMed |
| The VAX2-LINC01189-hnRNPF signaling axis regulates cell invasion and migration in gastric cancer. | Cell Death Discov | 2023 | 37865686 | PubTator, text mining | PubMed |
| Long Non-coding RNA Linc01224 Regulates Hypopharyngeal Squamous Cell Carcinoma Growth Through Interactions with miR-485-5p and IGF2BP3. | J Cancer | 2023 | 37859812 | PubTator, text mining | PubMed |
| Identification of lncRNAs associated with uterine corpus endometrial cancer prognosis based on the competing endogenous RNA network. | Int J Med Sci | 2023 | 37859697 | PubTator, text mining | PubMed |
| MicroRNAs, long non-coding RNAs, and circular RNAs and gynecological cancers: focus on metastasis. | Front Oncol | 2023 | 37854681 | PubTator, text mining | PubMed |
| Serum LINC00152 and UCA1 in HCV-Induced Hepatocellular Carcinoma: Clinical Significance and Prognostic Value. | Biologics | 2023 | 37854341 | PubTator, text mining | PubMed |
| PD-1/PD-L1 Inhibitors Response in Triple-Negative Breast Cancer: Can Long Noncoding RNAs Be Associated? | Cancers (Basel) | 2023 | 37835376 | PubTator, text mining | PubMed |
| LncRNA UCA1 promotes pancreatic cancer cell migration by regulating mitochondrial dynamics via the MAPK pathway. | Arch Biochem Biophys | 2023 | 37816421 | PubTator, text mining | PubMed |
| Exosome, the glass slipper for Cinderella of cancer-bladder cancer? | J Nanobiotechnology | 2023 | 37805491 | PubTator, text mining | PubMed |
| Potential roles of tumor microenvironment in gefitinib-resistant non-small cell lung cancer: A narrative review. | Medicine (Baltimore) | 2023 | 37800802 | PubTator, text mining | PubMed |
| The role of TXNIP in cancer: a fine balance between redox, metabolic, and immunological tumor control. | Br J Cancer | 2023 | 37794178 | PubTator, text mining | PubMed |
| Role of PPARG in Chemosensitivity-Regulating Network for Hypopharyngeal Squamous Cell Carcinoma. | PPAR Res | 2023 | 37791141 | PubTator, text mining | PubMed |
| Insights into the involvement of long non-coding RNAs in doxorubicin resistance of cancer. | Front Pharmacol | 2023 | 37781691 | PubTator, text mining | PubMed |
| Multifaceted role of mTOR (mammalian target of rapamycin) signaling pathway in human health and disease. | Signal Transduct Target Ther | 2023 | 37779156 | PubTator, text mining | PubMed |
| Modulation of wheatgrass (Triticum aestivum Linn) toxicity against breast cancer cell lines by simulated microgravity. | Curr Res Toxicol | 2023 | 37767028 | PubTator, text mining | PubMed |
| Host and HBV Interactions and Their Potential Impact on Clinical Outcomes. | Pathogens | 2023 | 37764954 | PubTator, text mining | PubMed |
| Role of Lnc-RNAs in the Pathogenesis and Development of Diabetic Retinopathy. | Int J Mol Sci | 2023 | 37762249 | PubTator, text mining | PubMed |
| Prognostic Biomarkers of Cell Proliferation in Colorectal Cancer (CRC): From Immunohistochemistry to Molecular Biology Techniques. | Cancers (Basel) | 2023 | 37760539 | PubTator, text mining | PubMed |
| A New Understanding of Long Non-Coding RNA in Hepatocellular Carcinoma-From m6A Modification to Blood Biomarkers. | Cells | 2023 | 37759495 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/652995/papers?page=12